In situ crosslinkable hydrogels formed from modified starch and O-carboxymethyl chitosan
- 9 March 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (38) , 30303-30309
Abstract
An in situ hydrogel based on oxidation cholesterol starch (OCS) and O-carboxymethyl chitosan (CMCT) that is completely devoid of potentially cytotoxic small molecule cross-linkers and does not require complex manoeuvres or catalysis has been formulated and characterized. The network structure was created by Schiff base formation. The mechanical properties, internal morphology and swelling ability of the injectable hydrogel were examined. Rheological measurements demonstrated that increasing the concentration of the monomer improved the storage modulus. SEM showed that the hydrogel possessed a well-defined porous structure. In addition, the Schiff base reaction was acid sensitive. Under acid conditions, the hydrogel could hydrolyse quickly compared with high pH conditions. Doxorubicin (DOX) was used as a model drug to investigate the control and release properties of the hydrogel. The cytotoxic potential of the hydrogel was determined using an in vitro viability assay with L929 cells as a model and the results revealed that the hydrogel was non-cytotoxic.Keywords
Funding Information
- National Natural Science Foundation of China (51103150, 51321062)
This publication has 51 references indexed in Scilit:
- Characterisation of the Clinical Pharmacokinetics of Actinomycin D and the Influence of ABCB1 Pharmacogenetic Variation on Actinomycin D Disposition in Children with CancerClinical Pharmacokinetics, 2014
- Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cellsBiomaterials, 2012
- Reversible Targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Dactinomycin and vincristine toxicity in the treatment of childhood cancer: A retrospective study from the Children's Oncology GroupPediatric Blood & Cancer, 2010
- Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imagingBiomaterials, 2010
- Hepatocellular Carcinoma: Management of an Increasingly Common ProblemBaylor University Medical Center Proceedings, 2008
- Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer–Dox–AGM in breast cancer cellsJournal of Controlled Release, 2007
- Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse ModelScience, 1998
- TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κBScience, 1996
- Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A gynecologic oncology group study (a final report)Cancer, 1985